InvestorsHub on MSN
Tarsus to receive $15M milestone after China approves TP-03 eye therapy
Tarsus Pharmaceuticals Inc. (NASDAQ:TARS) said it will receive a $15 million milestone payment after China’s National Medical Products Administration approved TP-03 (lotilaner ophthalmic solution) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results